Long-term survival and function of intrahepatic islet allografts in baboons treated with humanized anti-CD154

Diabetes

Volumn 48, Issue 7, 1999, Pages 1473-1481

  Kenyon, Norma S ^a   Fernandez, Luis A ^a   Lehmann, Roger ^a   Masetti, Michele ^a   Ranuncoli, Alessandra ^a   Chatzipetrou, Maria ^a   Iaria, Giuseppe ^a   Han, Dongmei ^a   Wagner, Joseph L ^a   Ruiz, Philip ^a   Berho, Mariana ^a   Inverardi, Luca ^a   Alejandro, Rodolfo ^a,b   Mintz, Daniel H ^a   Kirk, Allan D ^c   Harlan, David M ^c   Burkly, Linda C ^d   Ricordi, Camillo ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NAVAL MEDICAL RESEARCH CENTER   (United States)

^d BIOGEN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; TACROLIMUS;

ALLOGRAFT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOIMMUNITY; BABOON; CONTROLLED STUDY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE TREATMENT; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PANCREAS ISLET TRANSPLANTATION; PANCREAS RESECTION; PRIORITY JOURNAL; SURVIVAL;

ANIMALS; ANTIBODIES, MONOCLONAL; CD40 LIGAND; FEMALE; GRAFT SURVIVAL; HUMANS; ISLETS OF LANGERHANS TRANSPLANTATION; LIVER; MALE; MEMBRANE GLYCOPROTEINS; PAPIO; POSTOPERATIVE PERIOD; TIME FACTORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0033056692     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.7.1473     Document Type: Article

References (54)

1. Jindal RM, Sidner RA, Milgrom ML: Post-transplant diabetes mellitus: the role of immunosuppression. Drug Safety 4:242-257, 1997
2. Cecka JM: The UNOS scientific renal transplant registry: ten years of kidney transplants. Clin Transpl, 1-14, 1997
3. Hering BJ, Ricordi C: Islet transplantation for patients with type 1 diabetes. Graft 2:12-27, 1999
4. Scharp DW, Lacy PE, Santiago JV, McCullough CS, Weide LG, Falqui L, Marchetti P, Gingerich RL, Jaffe AS, Cryer PE, Anderson CB, Flye MW: Insulin independence after islet transplantation into a type I diabetic patient. Diabetes 39:515-518, 1990
5. Socci C, Falqui L, Davalli AM, Ricordi C, Braghi S, Bertuzzi F, Maffi P, Secchi A, Gavazzi F, Freschi M: Fresh human islet transplantation to replace pancreatic endocrine function in type I diabetic patients. Acta Diabetol 28:151-157, 1991
6. Warnock GL, Kneteman NM, Ryan E, Seelis REA, Rabinovitch A, Rajotte RV: Normoglycemia after transplantation of freshly isolated and cryopreserved pancreatic islets in type I (insulin-independent) diabetes mellitus. Diabetologia 34:55-58, 1991
7. Ricordi C, Tzakis AG, Carroll PB, Zeng Y, Rilo HLR, Alejandro R, Shapiro R, Fung JJ, Demetris AJ, Mintz DH, Starzl TE: Human islet isolation and allotransplantation in 22 consecutive cases. Transplantation 53:407-414, 1992
8. Gores PF, Najarian JS, Stephanian E, Lloveras JJ, Kelley SL, Sutherland DE: Insulin independence in type I diabetes after transplantation of unpurified islets from a single donor with 15-deoxyspergualin. Lancet 341:19-21, 1993
9. Alejandro R, Lehmann R, Ricordi C, Kenyon NS, Angelico MC, Burke G, Esquenazi V, Nery J, Betancourt AE, Kong SS, Miller J, Mintz DH: Long-term function (6 years) of islet allografts in type I diabetes. Diabetes 46:1983-1989, 1997
10. Foy TM, Aruffo A, Bajorath J, Buhlmann JE, Moelle RJ: Immune regulation by CD40 and its ligand GP39. Ann Rev Immunol 14:591-617, 1996
11. Grewal IS, Flavell RA: CD40 and CD154 in cell-mediated immunity. Ann Rev Immunol 16:111-135, 1998
12. Grewal IS, Flavell RA: The CD40 ligand: at the center of the immune universe. Immunol Res 16:59-70, 1997
13. Kirk AD, Harlan DM, Armstrong NN, Davis TA, Dong Y, Gray GS, Hong X, Thomas D, Fechner JH, Knechtle SJ: CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates. Proc Natl Acad Sci U S A 94:8789-8794, 1994
14. Kiener PA, Moran-Davis P, Rankin RM, Wahl AF, Aruffo A, Hollenbaugh D: Stimulation of CD40 with purified soluble gp39 induces proinflammatory responses in human monocytes. J Immunol 155:4917-4925, 1995
15. Shu U, Kiniwa M, Wu CY, Maliszewski C, Vezzio N, Hakimi H, Gately M, Delespesse G: Activated T cells induce interleukin-12 production by monocytes via CD40-CD40 ligand interaction. Eur J Immunol 25:1125-1128, 1995
16. Pradier O, Willems F, Abramowicz D, Schandene L, de Boer M. Thielemans K, Capel P, Goldman M: CD40 engagement induces monocyte procoagulant activity through an interleukin-10 resistant pathway. Eur J Immunol 26: 3048-3054, 1996
17. Hollenbaugh D, Mischel-Petty N, Edwards CP, Simon JC, Denfel RW, Kiener PA, Aruffo A: Expression of functional CD40 by vascular endothelial cells. J Exp Med 182:33-40, 1995
18. Déchanet J, Grosset C, Taupin JL, Merville P, Banchereau J, Ripoche J, Moreau JF: CD40 ligand stimulates proinflammatory cytokine production by human endothelial cells. J Immunol 159:5640-5647, 1997
19. Larsen CP, Alexander DZ, Hollenbaugh D, Elwood ET, Ritchie SC, Aruffo A, Hendrix R, Pearson TC: CD40-gp39 interactions play a critical role during allograft rejection: suppression of allograft rejection by blockade of the CD40-gp39-pathway. Transplantation 61:4-9, 1996
20. Larsen CP, Elwood ET, Alexander DZ, Ritchie SC, Hendrix R, Tucker-Burden C, Cho HR, Aruffo A, Hollenbaugh D, Linsley PS, Winn KJ, Pearson TC: Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381:434-438, 1996
21. Markees TG, Phillips NE, Noelle RJ, Schultz LD, Mordes JP, Greiner DL, Rossini AA: Prolonged survival of mouse skin allografts in recipients treated with donor splenocytes and antibody to CD40 ligand. Transplantation 64:329-335, 1997
22. Parker DC, Greiner DL, Phillips NE, Appel MC, Steele AW, Durie FH, Noelle RJ, Mordes JP, Rossini AA: Survival of mouse pancreatic islet allografts in recipients treated with allogeneic small lymphocytes and antibody to CD40 ligand. Proc Natl Acad Sci U S A 92:9560-9564, 1995
23. Lu L, Li W, Fu F, Chambers FG, Qian S, Fung JJ, Thomson AW: Blockade of the CD40-CD40 ligand pathway potentiates the capacity of donor-derived dendritic cell progenitors to induce long-term cardiac allograft survival. Transplantation 64:1808-1815, 1997
24. Harlan DM, Kirk AD: Anti-CD154 therapy to prevent allograft rejection. Graft 1:63-70, 1998
25. Datta SK, Kalled SL; CD40-CD40 ligand interaction in autoimmune disease. Arthritis Rheum 40:1735-1745, 1997
26. Grewal IS, Foellmer HG, Grewal KD, Xu J, Hardardottir F, Baron JL, Janeway CA, Flavell RA: Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 273: 1864-1867, 1996
27. Gerritse K, Laman JD, Noelle RJ, Aruffo A, Ledbetter JA, Boersma WJA, Claassen E: CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc Natl Acad Sci U S A 93: 2499-2504, 1996
28. Samoilova EB, Horton JL, Zhang H, Chen Y: CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation. J Mol Med 75:603-608, 1997
29. Early GS, Zhao W, Burns CM: Anti-CD40 ligand antibody treatment prevents the development of lupus-like nephritis in a subset of New Zealand black x New Zealand white mice: response correlates with the absence of an anti-antibody response. J Immunol 157:3159-3164, 1996
30. Kalled SL, Cutler AH, Datta SK, Thomas DW: Anti-CD40 ligand antibody treatment of SNF1 mice with established nephritis: preservation of kidney function. J Immunol 160:2158-2165, 1998
31. Biancone L, Andres G, Ahn H, DeMartino C, Stamenkovic I: Inhibition of the CD40-CD40 ligand pathway prevents murine membranous glomerulonephritis. Kidney Int 48:458-468, 1995
32. Mohan C, Shi Y, Laman JD, Datta SK: Interaction between CD40 and its ligand gp39 in the development of murine lupus nephritis. J Immunol 154: 1470-1480, 1995
33. Carayanniotis G, Masters SR, Noelle RJ: Suppression of murine thyroiditis via blockade of the CD40-CD40L interaction. Immunology 90:421-426, 1997
34. Balasa B, Krahl T, Patstone G, Lee J, Tisch R, McDevitt HO, Sarvetnick N: CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in non-obese diabetic mice. J Immunol 159:4620-4627, 1997
35. Durie FH, Aruffo A, Ledbetter J, Crassi KM, Green WR, Fast LD, Noelle RJ: Antibody to the ligand of CD40, gp39, blocks the occurrence of the acute and chronic forms of graft-versus-host disease. J Clin Invest 94:1333-1338, 1994
36. Saito K, Sakurai J, Ohata J, Kohsaka T, Hashimoto H, Okumura K, Abe R, Azuma M: Involvement of CD40 ligand-CD40 and CTLA4-B7 pathways in murine acute graft-versus-host disease induced by allogeneic T cell lacking CD28. J Immunol 160:4225-4231, 1998
37. + T cell-mediated alloreactivity by inhibiting mature donor T cell expansion and function after bone marrow transplantation. J Immunol 158:29-39, 1997
38. Lederman S, Yellin MJ, Inghirami G, Lee JJ, Knowles DM, Chess L: Molecular interactions mediating T-B lymphocyte collaboration in human lymphoid follicles: roles of T-cell-B-cell-activating molecule (5c8 antigen) and CD40 in contact-dependent help. J Immunol 149: 3817-3826, 1992
39. Institute of Laboratory Animal Resources: Guide for Care and Use of Laboratory Animals. Washington, DC, National Academy Press, 1996 (National Research Council, DHHS pub. no. 86-23 [19850])
40. Ricordi C, Lacy PE, Finke EH, Olack BJ, Scharp DW: Automated method for isolation of human pancreatic islets. Diabetes 37:413-420, 1988
41. Selvaggi G, Fernandez L, Bottino R, Lehmann R, Kenyon NS, Inverardi L, Ricordi C: Improved baboon pancreatic islet cell isolation. Transplant Proc 29:1967-1968, 1997
42. Robertson GS, Chadwick DR, Contractor H, James RF, London NJ: The optimization of large-scale density gradient isolation of human islets. Acta Diabetologica 30:93-98, 1993
43. Latif ZA, Noel J, Alejandro R: A simple method of staining fresh and cultured islets. Transplantation 45:827-830, 1988
44. Ricordi C, Gray DW, Hering BJ, Kaufman DB, Warnock GL, Kneteman NM, Lake SP, London NJ, Socci C, Alejandro R, Zeng Y, Scharp D, Viviani G, Falqui L, Tzakis A, Bretzel R, Federlin K, Pozza G, James RFL, Rajotte R, DiCarlo V, Morris PJ, Sutherland DER, Starzl T, Mintz DH, Lacy P: Islet isolation assessment in man and large animals. Acta Diabetol Lat 27:185-195, 1990
45. Ericzon BG, Wijnen RMH, Kubota K, van der Bogaard A, Kootstra G: Diabetes induction and pancreatic transplantation in the cynomolgus monkey: methodological considerations. Transpl Int 4:103-109, 1991
46. Fontes PA, Ricordi C, Rao AS, Rybka WB, Dodson SF, McAllister CG, Broznick B, Ukah FO, Fung JJ, Starzl TE: Human vertebral bodies as a source of bone marrow for augmentation in whole organ allografts. In Methods in Celt Transplantation. Ricordi C, Ed. Austin, TX, R.G. Landes, 1995, p. 619-628
47. Lehmann R, Wagner JL, Fernandez LA, Bourgoignie JJ, Ricordi C, Alejandro R, Kenyon NS: Effects of ketamine sedation on glucose clearance, insulin secretion and counterregulatory hormone production in baboons (Papio hamadryas). J Med Primatol 26:312-321, 1997
48. Teuscher AU, Kendall DM, Smets YFC, Leone JP, Sutherland DER, Robertson RP: Successful islet autotransplantation in humans: functional insulin secretory reserve as an estimate of surviving islet cell mass. Diabetes 47:324-330, 1998
49. Levisetti MG, Padrid PA, Szat GL, Mittal N, Meehan SM, Wardrip CL, Gray GS, Bruce DS, Thistlethwaite JR Jr, Bluestone JA: Immunosuppressive effect of human CTLA4-Ig in a non-human primate model of allogeneic pancreatic islet transplantation. J Immunol 159:5187-5191, 1997
50. Bennett SR, Carbone FR, Karamalis F, Flavell RA, Miller JF, Heath WR: Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature 393:478-480, 1998
51. + T-helper and a T-killer cell. Nature 393:474-478, 1998
52. Schoenberger SP, Toes REM, van der Voort EI, Offringa R, Melief CJM: T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature 393:480-483, 1998
53. Bottino R, Fernandez L, Ricordi C, Lehmann R, Tsan MF, Oliver R, Inverardi L: Transplantation of allogeneic islets of Langerhans in the rat liver effects of macrophage depletion on graft survival and microenvironment activation. Diabetes 47:316-323, 1998
54. Kaufman DB, Gores PF, Field MJ, Farney AC, Gruber SA, Stephanian E, Sutherland DE: Effect of 15-deoxyspergualin on immediate function and long-term survival of transplanted islets in murine recipients of a marginal islet mass. Diabetes 43:778-783, 1994